Home/ Supplements/ Melatonin/ Melatonin 3 mg

Melatonin 3 mg

product on market Tablet or Pill Wonder Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is a hormone that helps regulate sleep-wake cycles and may reduce sleep onset latency. There is strong evidence supporting its use for short-term management of jet lag and certain sleep disorders. This specific formulation provides a 3 mg dose of the single active ingredient.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin 3 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetable Tablet(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

3 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Calcium Carbonate Vegetable Cellulose Vegetable Magnesium Silicate Stearic Acid Vegetable Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults, take 1-2 vegetable tablets 20 minutes before bedtime. Read warning section of label prior to taking product. Do not exceed two tablets in any 24 hour period.

Warnings & Precautions

Tamper evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Warning: This product is not to be taken by pregnant or lactating women, individuals with autoimmune conditions or depressive disorders, or children under 16 years of age.

This product is not to be taken by pregnant or lactating women, individuals with autoimmune conditions or depressive disorders, or children under 16 years of age.

This product is not to be taken by pregnant or lactating women, individuals with autoimmune conditions or depressive disorders, or children under 16 years of age. Do not take this product when driving a motor vehicle or operating machinery.

Formulation Notes

Suitable for Vegetarians/Vegans.

Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs)

Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Nutritionally supports a healthy sleep pattern

Gluten free

Additional Information

Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

Formula 743

Fast acting

Made in USA

Metadata

Product Details

UPC / SKU0 99528 74324 7
DSLD Entry Date2020-03-24
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID215481
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.